N2Growth Blog
OCTOBER 23, 2023
As the sector evolves and expands, companies increasingly turn to executive search firms like N2Growth to help them identify and recruit top talent for critical leadership roles. The life sciences industry is known for its unique challenges in recruiting and hiring.
TechCrunch
MARCH 21, 2023
When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
CIO
SEPTEMBER 18, 2023
When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.
TechCrunch
NOVEMBER 17, 2020
As Italy reinstates many COVID-19 restrictions, the country’s tech ecosystem is watching and waiting to see what the wider effects of the emergency will be. Italy’s ecosystem for tech venture capital and startups has been in development for years and has made decent strides in the last decade.
TechCrunch
MARCH 23, 2021
Meatable has a long road ahead of it, because, as Gates acknowledged in his interview with MIT Technology Review (ed. These products don’t get at the full potential for cellular technology according to Daan Luining, Meatable’s chief technology officer. ” For Meatable right now, price remains an issue.
TechCrunch
SEPTEMBER 7, 2021
a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. A 2020 review paper in Bioengineering notes the organ-on-a-chip industry was recently valued around $21 million, but could grow to about $220 million by 2025. . Emulate Inc.,
Pandora's Brain
JULY 7, 2023
Human chemists in around 40 Contract Research Organisations (CROs), mostly in China and India, review the most promising 100 or so of the resulting molecules, and around 15-20 of them are synthesised and tested. The characteristics of the best performing molecules are fed back into the array of generative AI systems for further review.
Expert insights. Personalized for you.
175 
Let's personalize your content